Abstract: The invention relates to a method for producing a holographic optical element by providing a recording stack comprising at least one recording element laminated on at least one supporting element, irradiating at least a part of the recording stack with at least one recording beam in an irradiating step, wherein during the irradiating step, the recording stack bends, providing a bending deviation threshold for the recording stack, and adjusting at least one first process parameter such that an expected maximum bending deviation of the recording stack does not exceed the bending deviation threshold, wherein the at least one first process parameter influences the bending behaviour of the recording stack during the irradiating step.

Abstract: The invention relates to a method for producing a holographic optical element by providing a recording stack comprising at least one recording element laminated on at least one supporting element, irradiating at least a part of the recording stack with at least one recording beam in an irradiating step, wherein during the irradiating step, the recording stack bends, providing a bending deviation threshold for the recording stack, and adjusting at least one first process parameter such that an expected maximum bending deviation of the recording stack does not exceed the bending deviation threshold, wherein the at least one first process parameter influences the bending behavior of the recording stack during the irradiating step.

Abstract: A fuel system includes an air and fuel mixer configured to mix air and fuel provided to a combustion engine and a fuel path coupled to the air and fuel mixer. The fuel path includes an electronically controlled fuel control valve configured to regulate an air to fuel ratio of an air/fuel mixture provided to the engine, a gas pressure regulator disposed upstream of the fuel control valve and configured to control a pressure of the fuel in relation to an air pressure of the air and fuel mixer, and a manual adjust valve disposed downstream of the gas pressure regulator and configured to mechanically tune a performance of the fuel path to minimize an adjustment by the electronically controlled fuel control valve to regulate the air to fuel ratio. The fuel system is configured to operate with different fuels that differ in physical and chemical properties.

Abstract: A dual fuel system for a combustion engine includes an air and fuel mixer configured to mix air and fuel provided to the combustion engine, a first fuel path for a first fuel, and a second fuel path for a second fuel. The first and second fuels have different physical and chemical properties. The dual fuel system also includes a common fuel path coupled to the air and fuel mixer and both the first and second fuel paths, wherein the common fuel path includes an electronically controlled valve configured to regulate the air to fuel ratio of an air/fuel mixture provided to the combustion engine in response to control signals from a controller, and both the first and second fuel paths are coupled to the common fuel path at a location upstream of the electronically controlled valve.

Abstract: A fuel system includes an air and fuel mixer configured to mix air and fuel provided to a combustion engine and a fuel path coupled to the air and fuel mixer. The fuel path includes an electronically controlled fuel control valve configured to regulate an air to fuel ratio of an air/fuel mixture provided to the engine, a gas pressure regulator disposed upstream of the fuel control valve and configured to control a pressure of the fuel in relation to an air pressure of the air and fuel mixer, and a manual adjust valve disposed downstream of the gas pressure regulator and configured to mechanically tune a performance of the fuel path to minimize an adjustment by the electronically controlled fuel control valve to regulate the air to fuel ratio. The fuel system is configured to operate with different fuels that differ in physical and chemical properties.

Abstract: A dual fuel system for a combustion engine includes an air and fuel mixer configured to mix air and fuel provided to the combustion engine, a first fuel path for a first fuel, and a second fuel path for a second fuel. The first and second fuels have different physical and chemical properties. The dual fuel system also includes a common fuel path coupled to the air and fuel mixer and both the first and second fuel paths, wherein the common fuel path includes an electronically controlled valve configured to regulate the air to fuel ratio of an air/fuel mixture provided to the combustion engine in response to control signals from a controller, and both the first and second fuel paths are coupled to the common fuel path at a location upstream of the electronically controlled valve.

Abstract: A tool for facilitating threading of a flexible filament or sheet into a hole or opening. The tool includes (i) a filament or sheet guide having a longitudinally extending trough, and (2) an alignment system with (A) a first registration surface configured and arranged to transversely align a hole in a target-piece with the trough when the target-piece abuts the first registration surface, and (B) a second registration surface configured and arranged to laterally align a hole in a target-piece with the trough when the target-piece abuts the second registration surface. Threading of the filament or sheet into the hole or opening can then be achieved by simply causing an upward deflection of a distal portion of the flexible filament or sheet within the trough and moving the deflected distal portion of the filament or sheet along the length of the trough towards the aligned hole or opening in the target-piece until the distal end portion enters the hole or opening.

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases

Abstract: This invention relates to chroman derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations. The chroman derivatives of the present invention have an excellent activity as BETA 3 antagonists and are useful for the prophylaxis and treatment of diseases associated with BETA 3 activity, in particular for the treatment of urological disorder or disease, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor oeractivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; and inflammatory disorders, such as asthma and COPD.

Abstract: The present invention relates to compounds of the general formula (I), their preparation and use as pharmaceutical compositions asintegrin antagonists, especially as ?4? and/or ?4?7 ?and/or ?9?1 intergrin antagonists and in particular for the production of pharmaceutical compositions suitable for the inhibition or the prevention of cell adhesion and cell-adhesion mediated disorders. Examples are the treatment and the prophylaxis of atherosclerosis, asthma, chronic obstructive pulmonary disease (COPD), allergies, diabetes, inflammatory bowel disease, multiple sclerosis, myocardial ischemia, rheumatoid arthritis, transplant rejection and other inflammatory, autoimmune and immune disorders.

Abstract: The present invention relates to compounds of the general formula (I), 1

Abstract: The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: The present invention relates to compounds of general formula (I), processes for their preparation, pharmaceutical compositions containing them as well as their use for the production of pharmaceutical compositions for the treatment of inflammatory diseases.

Abstract: A disposable biological test pack for determining the efficacy of ETO gas sterilizers comprising a plastic housing which in turn houses a plastic vial holding biological spores. The plastic housing is closed at one end by a rubber cap and at the other end by an end plug with a porous paper/plastic insert or plug which allows sterilant to enter the tube in metered amounts to kill the biological spores contained within a plastic vial otherwise referred to as a self-contained biological indicator. If insufficient sterilant is present the biological spores will survive upon incubation which indicates a failure of the sterilization equipment. The present invention is unique in that it uses low porosity filter material to restrain the entry of the sterilant. By doing so the test pack stimulates the performance of the AAMI standard test pack.